Utilizing Engineered E. Coli as an Asymmetric Reducing Biocatalyst Towards Serotonin Reuptake Inhibitors, Richard J. Hammond, Benjamin W. Poston, Brent D. Feske
Department of Chemistry and Biochemistry Faculty Presentations

Utilizing an Engineered E. Coli Library as an Asymmetric Biocatalyst Towards Pharmaceutical Precursors., Brent D. Feske, Richard J. Hammond, Benjamin W. Poston, Scott C. Mateer, Todd J. Hizer
Department of Chemistry and Biochemistry Faculty Presentations

A Novel Biocatalytic Strategy Towards Prozac® and Other Serotonin Reuptake inhibitors, Benjamin W. Poston, Richard J. Hammond, Brent D. Feske
Department of Chemistry and Biochemistry Faculty Presentations

A Novel Biocatalytic Strategy Towards Prozac® and Other Serotonin Reuptake inhibitors, Benjamin W. Poston, Richard J. Hammond, Brent D. Feske
Department of Chemistry and Biochemistry Faculty Presentations

Biocatalytic Synthesis Towards Both Antipodes of 3-hydroxy-3-phenylpropanitrile a Precursor to Fluoxetine, Atomoxetine and Nisoxetine, Richard J. Hammond, Benjamin W. Poston, Ion Ghiviriga, Brent D. Feske
Department of Chemistry and Biochemistry Faculty Publications